DECAY-ACCELERATING FACTOR (CD55), A GLYCOSYLPHOSPHATIDYLINOSITOL-ANCHORED COMPLEMENT REGULATORY PROTEIN, IS A RECEPTOR FOR SEVERAL ECHOVIRUSES

被引:256
|
作者
BERGELSON, JM
CHAN, M
SOLOMON, KR
STJOHN, NF
LIN, HM
FINBERG, RW
机构
[1] Laboratory of Infectious Diseases, Dana-Farber Cancer Institute, Harvard Medical School, Boston
关键词
VIRUS RECEPTOR; PICORNAVIRUS; ECHOVIRUS; 7;
D O I
10.1073/pnas.91.13.6245
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Echoviruses are human pathogens belonging to the picornavirus family. Decay-accelerating fatter (DAF) is a glycosylphosphatidylinositol (GPI)-anchored surface protein that protects cells from lysis by autologous complement. Anti-DAF monoclonal antibodies prevented echovirus 7 attachment to susceptible cells and protected cells from infection. HeLa cells specifically lost the capacity to bind echovirus 7 when treated with phosphatidylinositol-specific phospholipase C, an enzyme that releases GPI-anchored proteins from the cell surface, indicating that the virus receptor, like DAF, is a GPI-anchored protein. Although Chinese hamster ovary cells do not bind echovirus 7, transfectants expressing human DAF bound virus efficiently, and binding was prevented by pretreatment with an anti-DAF monoclonal antibody. Anti-DAF antibodies prevented infection by at least six echovirus serotypes. These results indicate that DAF is the receptor mediating attachment and infection by several echoviruses.
引用
收藏
页码:6245 / 6248
页数:4
相关论文
共 50 条
  • [1] Signal transduction via a protein associated with a glycosylphosphatidylinositol-anchored protein, decay-accelerating factor (DAF/CD55)
    Kuraya, M
    Fujita, T
    INTERNATIONAL IMMUNOLOGY, 1998, 10 (04) : 473 - 480
  • [2] Congenital Defects in the Expression of the Glycosylphosphatidylinositol-Anchored Complement Regulatory Proteins CD59 and Decay-Accelerating Factor
    Kinoshita, Taroh
    SEMINARS IN HEMATOLOGY, 2018, 55 (03) : 136 - 140
  • [3] Cardiovirulent coxsackieviruses and the decay-accelerating factor (CD55) receptor
    Martino, TA
    Peric, M
    Brown, M
    Aitken, K
    Gauntt, CJ
    Richardson, CD
    Chow, LH
    Liu, PP
    VIROLOGY, 1998, 244 (02) : 302 - 314
  • [4] CRYSTALLOGRAPHIC STUDIES OF DECAY-ACCELERATING FACTOR (CD55)
    Lukacik, P.
    Billington, J.
    Heinrich, A.
    Thurston, K.
    Smith, G.
    White, J.
    Smith, R. A.
    Lea, S. M.
    ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES, 2002, 58 : C281 - C281
  • [5] STRUCTURE AND FUNCTION OF DECAY-ACCELERATING FACTOR CD55
    NICHOLSONWELLER, A
    WANG, C
    JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 1994, 123 (04): : 485 - 491
  • [6] The HeLa cell receptor for enterovirus 70 is decay-accelerating factor (CD55)
    Karnauchow, TM
    Tolson, DL
    Harrison, BA
    Altman, E
    Lublin, DM
    Dimock, K
    JOURNAL OF VIROLOGY, 1996, 70 (08) : 5143 - 5152
  • [7] EXPRESSION OF DECAY-ACCELERATING FACTOR (CD55) OF THE COMPLEMENT-SYSTEM ON HUMAN SPERMATOZOA
    CERVONI, F
    OGLESBY, TJ
    FENICHEL, P
    DOHR, G
    ROSSI, B
    ATKINSON, JP
    HSI, BL
    JOURNAL OF IMMUNOLOGY, 1993, 151 (02): : 939 - 948
  • [8] Decay-accelerating factor (CD55) deficiency phenotypes in Japanese
    Daniels, GL
    Green, CA
    Mallinson, G
    Okubo, Y
    Hori, Y
    Kataoka, A
    Kaihara, M
    TRANSFUSION MEDICINE, 1998, 8 (02) : 141 - 147
  • [9] DEFICIENCY OF COMPLEMENT DECAY-ACCELERATING FACTOR (DAF, CD55) IN NON-HODGKINS-LYMPHOMA
    FUKUDA, H
    SEYA, T
    HARA, T
    MATSUMOTO, M
    KINOSHITA, T
    MASAOKA, T
    IMMUNOLOGY LETTERS, 1991, 29 (03) : 205 - 210
  • [10] Complement decay accelerating factor (DAF)/CD55 in cancer
    Spendlove, I
    Ramage, JM
    Bradley, R
    Harris, C
    Durrant, LG
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2006, 55 (08) : 987 - 995